Related content

Overlapping effects of genetic variation and epigenetics on drug response: challenges of pharmacoepigenomics

By Cascorbi Ingolf  

Pharmacogenomics, Vol. 14, Iss. 15, 2013-11 ,pp. : 1807-1809

Future Medicine

Access to resources Recommend Favorite

Functional diversity of the glutathione peroxidase gene family among human populations: implications for genetic predisposition to disease and drug response

By Polimanti Renato   Fuciarelli Maria   Destro-Bisol Giovanni   Battaggia Cinzia  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1037-1045

Future Medicine

Access to resources Recommend Favorite

Immunotherapy for Drug Abuse

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 8, 2011-01 ,pp. : 876-879

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Epigenetics: A Novel Frontier For Drug Discovery

By  

Current Medicinal Chemistry, Vol. 24, Iss. 37, 2017-12 ,pp. : 4103-4103

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

By  

Current Pharmaceutical Design, Vol. 19, Iss. 29, 2013-09 ,pp. : 5219-5238

Bentham Science Publishers

Access to resources Recommend Favorite